Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer In Vitro and In Vivo.
Clin Cancer Res. 2018 Aug 15;24(16):3994-4005. doi: 10.1158/1078-0432.CCR-17-3575. Epub 2018 May 1.
Clin Cancer Res. 2018.
PMID: 29716919
Free PMC article.